More Web Proxy on the site http://driver.im/

Drug development in IBD: from novel target identification to early clinical trials

Gut. 2016 Aug;65(8):1233-9. doi: 10.1136/gutjnl-2016-311717. Epub 2016 May 10.

Authors

Silvio Danese¹, Claudio Fiocchi², Julián Panés³

Affiliations

¹ IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Humanitas University, Milan, Italy.
² Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, Ohio, USA Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
³ Gastroenterology Department, Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.

PMID: 27196598
DOI: 10.1136/gutjnl-2016-311717

No abstract available

Keywords: IBD; IBD CLINICAL; IBD MODELS.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antibodies, Monoclonal, Humanized / therapeutic use*
Clinical Trials as Topic
Evidence-Based Medicine
Gastrointestinal Agents / therapeutic use*
Humans
Inflammatory Bowel Diseases / drug therapy*
Models, Animal

Substances

Antibodies, Monoclonal, Humanized
Gastrointestinal Agents